REGENXBIO (RGNX) Ownership - Who owns REGENXBIO?

Industry: @Biotechnology
17 days until earnings call

Profile

Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
619.64M
P/E Ratio
N/A
Total Cash
338.7M
Projected Growth
N/A
Total Debt
87.25M
Revenue
86.73M
Risk (Beta)
1.20
Dividend Yield
N/A
Total Cash/Share
6.88
Total Debt/Equity
N/A
Revenue/Share
1.96 USD as % of share price

Fundamentals

RGNX
Capitalization
620M
P/E Ratio
N/A
Risk (Beta)
1.20
Dividend Yield
N/A
Total Cash
339M
Total Cash/Share
6.88
Total Debt
87.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.96%
Revenue
86.7M
ROE
N/A
Book Value
391M
P/B Ratio
1.59
Cash Flow
N/A
Earnings
-5.87
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
3.59
Current Revenue Per Employee
45412.79
Dividends Per Share - Security
N/A
EBITDA
-236.9M
Float
N/A
Float - Current
N/A
Gross Income Margin
72.58
Revenue To Assets
-37.78
Shares Held By Institutions
1.21B
Shares Outstanding - Current
49.3M
Total Liabilities
239M
Total Volume MTD
N/A
Value
-1
Gain YTD
-29.916
View a ticker or compare two or three
RGNX
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of gene therapy treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com